- Previous Close
241.05 - Open
254.85 - Bid 236.50 x --
- Ask 240.85 x --
- Day's Range
235.10 - 254.85 - 52 Week Range
221.10 - 330.00 - Volume
855 - Avg. Volume
1,954 - Market Cap (intraday)
766.105M - Beta (5Y Monthly) 1.06
- PE Ratio (TTM)
12.79 - EPS (TTM)
18.84 - Earnings Date May 26, 2025 - May 30, 2025
- Forward Dividend & Yield 2.00 (0.79%)
- Ex-Dividend Date Sep 23, 2024
- 1y Target Est
--
Vasundhara Rasayans Limited engages in the manufacture and sale of antacids therapeutic category of active pharmaceutical ingredients (API) in India and internationally. It offers aluminum hydroxide gel, magnesium hydroxide, magaldrate, magnesium trisilicate, magnesium silicate, aluminum phosphate. The company also provides aluminum sulphate, aluminum hydroxide amorphous, and poly aluminum chloride for various applications of water treatment, aluminum salts, etc. In addition, it provides organic API and dyes intermediates; and aluminum hydroxide gel low heavy lead content for lake color. The company offers its products in various forms, such as paste, powder, and micronized grade powder. It supplies its products to the pharmaceutical, food, and chemical industries, as well as provides technical backup support services. The company also exports its products. Vasundhara Rasayans Limited was incorporated in 1987 and is based in Hyderabad, India. Vasundhara Rasayans Limited is a subsidiary of P&J Cretechem Private Limited.
www.vrlindia.inRecent News: VRL.BO
View MorePerformance Overview: VRL.BO
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VRL.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VRL.BO
View MoreValuation Measures
Market Cap
765.79M
Enterprise Value
757.65M
Trailing P/E
12.78
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.05
Price/Book (mrq)
2.07
Enterprise Value/Revenue
2.03
Enterprise Value/EBITDA
8.74
Financial Highlights
Profitability and Income Statement
Profit Margin
16.02%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
373.73M
Net Income Avi to Common (ttm)
59.89M
Diluted EPS (ttm)
18.84
Balance Sheet and Cash Flow
Total Cash (mrq)
17.46M
Total Debt/Equity (mrq)
2.52%
Levered Free Cash Flow (ttm)
--